subscribeSubscribe
Amneal`s Generic Medroxyprogesterone Acetate Receives Approval in the U.S.

Amneal`s Generic Medroxyprogesterone Acetate Receives Approval in the U.S.
FDA
07 Jun 2023
Share Share
Hikma`s Generic Medroxyprogesterone Acetate Receives Approval in the U.S.

Hikma`s Generic Medroxyprogesterone Acetate Receives Approval in the U.S.
FDA
05 Jan 2023
Share Share
Eugia`s Generic Medroxyprogesterone Acetate Receives Approval in the U.S.

Eugia`s Generic Medroxyprogesterone Acetate Receives Approval in the U.S.
FDA
31 Aug 2022
Share Share
Eugia`s Generic Medroxyprogesterone Acetate Receives Approval in the U.S.

Eugia`s Generic Medroxyprogesterone Acetate Receives Approval in the U.S.
FDA
22 Aug 2022
Share Share
Enforcement Report - Week of June 22, 2022

Enforcement Report - Week of June 22, 2022
FDA
22 Jun 2022
Share Share
Enforcement Report - Week of February 9, 2022

Enforcement Report - Week of February 9, 2022
FDA
09 Feb 2022
Share Share
Enforcement Report - Week of November 17, 2021

Enforcement Report - Week of November 17, 2021
FDA
17 Nov 2021
Share Share
Sun Pharms Generic Medroxyprogesterone Acetate Receives Approval in US

Sun Pharms Generic Medroxyprogesterone Acetate Receives Approval in US
FDA
29 Apr 2019
Share Share
Cipla`s Generic Medroxyprogesterone Acetate Receives Approval in US

Cipla`s Generic Medroxyprogesterone Acetate Receives Approval in US
FDA
25 Jan 2019
Share Share
Specialty Generics: Barriers To Uptake

Specialty Generics: Barriers To Uptake
Joshua Cohen FORBES
13 Nov 2018
Share Share